Life Sciences Report Collection
Stem Cell Therapeutics for Oncology: Technologies and Global Mark...
The global stem cell anticancer therapeutics market was valued at $859 million in 2010. This market is expected to increase at an 11.3% compound annual growth rate (CAGR) to reach nearly $1.5 billion in 2015.
Markets for Emerging Pharmaceutical Technologies
As a segment, therapeutic vaccines recorded $19.3 billion in 2010, a figure that is expected to grow to $31.9 billion by 2015, demonstrating a compound annual growth rate (CAGR) of 10.6%.
Emerging Regional Markets for Therapeutic Drugs
The overall emerging markets for therapeutic drugs totaled $131.4 billion in 2009. These regions include Latin America, China, Eastern Europe, the Middle East, South Korea, India, Russia, and South Africa. These regions are estimated at $145.8 billion in 2010 and expected to continue aggressive growth through 2015, reaching a figure of $214.2 billion, yielding a compound annual growth rate (CAGR) of 8% from 2010 to 2015.
The Clinical Trials Business
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period. Clinical trial spending in 2010 is an estimated $25 billion and is expected to reach $28.5 billion by 2014.
Therapeutics for Immune System Disorders
In 2010, the global market for drugs for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.
Therapeutic Drugs for Central Nervous System (CNS) Disorders: Tec...
This study provides a comprehensive analysis of central nervous system therapies on a global basis. It provides a range of information, from detailed product analyses within disease sub-segments to overall industry trends, in order to quantify and qualify the market for therapeutic drug products in the central nervous system sector.
Oncology Adjuvants: Technologies and Global Markets
This report covers the current status of the global oncolytic adjuvant marketplace and assess its growth potential over the five-year period from 2010 to 2015
Cardiovascular Therapeutic Drugs: Technologies and Global Markets
This study provides a comprehensive analysis of cardiovascular therapies on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the market for therapeutic drug products in the cardiovascular segment. Includes forecasts through 2015
Therapeutics and Biomaterials for Musculoskeletal Disease: Global...
Determine the current status of the musculoskeletal disease (MSD) treatments and assess the growth potential of this area over a 5-year period from 2009 to 2014.
Osteoporosis Drugs: Technologies and Global Markets
This study describes the industry structure and major participants in the osteoporosis drugs market, market dynamics and competitive aspects, current developments and future market trends, to assist in understanding the market and identifying areas of commercial interest and potential in osteoporosis. Includes forecasts through 2014
Biotechnologies for Medical Applications: Global Markets
The report addresses the global market for biotechnologies used in medical and healthcare-related applications during the period from 2009 through 2015.
Contraceptives: Technologies and Global Markets
A detailed analysis of the contraceptive industry structure, which includes the manufacturing of various types of contraceptives. Revenues are broken down by region. Sales figures are estimated for the 5–year period from 2010 through 2015.
Autacoids and Related Drugs: Technologies and Global Markets
This BCC report presents a comprehensive analysis of the current market for autacoids and related drugs and its future direction. It also examines the x biologic activity and usage of autacoids in the treatment of various diseases. Includes forecasts through 2015
New Developments in Treating Genetic Disorders: The Global Market
The goal of the study is to provide an overview of a range of genetic disorders, both mutation and chromosomal in nature, and provide market summaries and new research and developments. The market is discussed for the 2009 year and forecasts are provided through 2014. Product descriptions, discussions of new research, and company profiles are also provided.
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics an...
BCC's goal for this study was to examine the status of commercial epigenomics technologies and products and assess their worldwide growth potential over a 5-year period from 2009 to 2014. We analyzed the four important market segments for epigenomics: research tools, diagnostics, therapeutics, and assays for cellular therapies.
Emerging Markets for Advanced Medical Technologies
The overall goal of this study is to provide the reader with an understanding of the demographic, economic, policy, and regulatory forces that will influence the future size and structure of the market for advanced medical devices in the largest emerging markets. Includes forecasts through 2014
Therapeutic Vaccines: The Global Market
This BCC market research report determines the current status of the therapeutic vaccines industry and assess its growth potential over a 5-year period from 2010 to 2015
Medical Device Sensors: Technologies and Global Markets
Research report on Medical Device Sensors: Technologies and Global Markets. Includes forecasts through 2014
Therapies for Depressive and Anxiety Disorders
Research report on the Global Market for Therapies for Depressive and Anxiety Disorders. Includes forecasts through 2014
The Global Market for Equipment Used in Biotechnology Application...
Research report on the Global Market for Equipment Used in Biotechnology Applications. Includes forecasts through 2014
